Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy.
Petrushev B, Boca S, Simon T, Berce C, Frinc I, Dima D, Selicean S, Gafencu GA, Tanase A, Zdrenghea M, Florea A, Suarasan S, Dima L, Stanciu R, Jurj A, Buzoianu A, Cucuianu A, Astilean S, Irimie A, Tomuleasa C, Berindan-Neagoe I. Petrushev B, et al. Among authors: tomuleasa c. Int J Nanomedicine. 2016 Feb 15;11:641-60. doi: 10.2147/IJN.S94064. eCollection 2016. Int J Nanomedicine. 2016. PMID: 26929621 Free PMC article.
KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma.
Pasca S, Tomuleasa C, Teodorescu P, Ghiaur G, Dima D, Moisoiu V, Berce C, Stefan C, Ciechanover A, Einsele H. Pasca S, et al. Among authors: tomuleasa c. Front Oncol. 2019 Oct 24;9:1137. doi: 10.3389/fonc.2019.01137. eCollection 2019. Front Oncol. 2019. PMID: 31709194 Free PMC article.
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.
Fuentes-Mattei E, Bayraktar R, Manshouri T, Silva AM, Ivan C, Gulei D, Fabris L, Soares do Amaral N, Mur P, Perez C, Torres-Claudio E, Dragomir MP, Badillo-Perez A, Knutsen E, Narayanan P, Golfman L, Shimizu M, Zhang X, Zhao W, Ho WT, Estecio MR, Bartholomeusz G, Tomuleasa C, Berindan-Neagoe I, Zweidler-McKay PA, Estrov Z, Zhao ZJ, Verstovsek S, Calin GA, Redis RS. Fuentes-Mattei E, et al. Among authors: tomuleasa c. JCI Insight. 2020 Jan 16;5(1):e121781. doi: 10.1172/jci.insight.121781. JCI Insight. 2020. PMID: 31941838 Free PMC article.
Targeting the Microenvironment in MDS: The Final Frontier.
Teodorescu P, Pasca S, Dima D, Tomuleasa C, Ghiaur G. Teodorescu P, et al. Among authors: tomuleasa c. Front Pharmacol. 2020 Jul 9;11:1044. doi: 10.3389/fphar.2020.01044. eCollection 2020. Front Pharmacol. 2020. PMID: 32742264 Free PMC article. Review.
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
Teodorescu P, Pasca S, Jurj A, Gafencu G, Joelsson JP, Selicean S, Moldovan C, Munteanu R, Onaciu A, Tigu AB, Buse M, Zimta AA, Stiufiuc R, Petrushev B, Desmirean M, Dima D, Vlad C, Bergthorsson JT, Berce C, Ciurea S, Ghiaur G, Tomuleasa C. Teodorescu P, et al. Among authors: tomuleasa c. J Cell Mol Med. 2020 Oct;24(19):11100-11110. doi: 10.1111/jcmm.15526. Epub 2020 Sep 5. J Cell Mol Med. 2020. PMID: 32889753 Free PMC article.
213 results